Lewes, DE -- (SBWIRE) -- 07/10/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Vapor Corp., (OTCMKTS:VPCO), ScripsAmerica, Inc. (OTCBB:SCRC), Titan Pharmaceuticals, Inc. (OTCBB:TTNP), American Graphite Technologies Inc (OTCBB:AGIN)
Vapor Corp., (OTCMKTS:VPCO) declined -1.72%, trading on 336,594 shares to end the trade at $1.14. The stock changed hands in a range of $1.09 to $1.18, bringing its market capitalization at about $68.61 million. If we look at its trading history of past 52 weeks, the share price suffered low of $0.15 and was moved to maximum level of $1.50. Vapor Corp. designs, markets, and distributes electronic cigarettes and accessories primarily in the United States and Canada. The companys electronic cigarettes are battery-powered products that enable users to inhale nicotine vapor without smoke, tar, ash, or carbon monoxide.
Has VPCO Found The Bottom And Ready To Gain Momentum? Find Out Here
ScripsAmerica, Inc. (OTCBB:SCRC) added 9.93% to complete the trading session at $0.748 with a total volume of 598,989 shares. The stock, on average, trades on a volume of 346,693 shares. It floated in a range of $0.58 to $0.75. Its market capitalization now moved to about $42.16 million. In the past 52 weeks, the share price has not declined below $0.11 and above $0.75. ScripsAmerica, Inc. engages in the distribution of pharmaceutical products in the United States. It delivers pharmaceutical products, including pain, arthritis, prenatal, urinary, and hormonal replacement drugs to a range of customers across the health care industry, including physician offices, retail pharmacies, long-term care sites, hospitals, and Government and home care agencies. The company was founded in 2008 and is based in New Castle, Delaware.
What was the Moving Force behind SCRC on Bullish Run? Read This Research Report
Titan Pharmaceuticals, Inc. (OTCBB:TTNP) added 18.91% and was in a range of $0.54-$0.65 before closing at $0.640. The stock completed the day with a total volume of 630,367 shares versus an average volume of 301,857 shares. The share price hit its 52-week low of $0.32 and $2.53 was the best price. Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States.
For How Long TTNP will fight for Profitability? Read This Trend Analysis report
American Graphite Technologies Inc (OTCBB:AGIN) declined -6.16% yesterday, bringing its market capitalization around $34.42 million. The share price after opening at $0.49 made a high of $0.49 and hovered above $0.42 to end the day at $0.440. The total number of shares changed hands during the session was 772,767 shares as compared to average trading volume of 461,671 shares. American Graphite Technologies Inc., an exploration stage company, focuses on the acquisition, exploration, and development of graphite related mineral properties primarily in the United States. The company was formerly known as Green & Quality Home Life, Inc. and changed its name to American Graphite Technologies Inc. in July 2012. American Graphite Technologies Inc. was founded in 2010 and is based in Las Vegas, Nevada.
Why Should Investors Buy AGIN After the Recent Fall? Just Go Here and Find Out
LeadingStockAlertsis a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/